Gachon University
Also known as: Cardiology, Gil Heart Center, Gachon Medical School | Chan-Yong Jeon | Clinical Trials Center, Gil Medical Center, Incheon, Korea | GachonGill Medical Center | Gachon Kil Medical Center | Gachon University Gil Medical Center | Gachon University Gil Medical Center, Incheon, Korea | Gachon University Gil Medical Center, Incheon, Republic of Korea | Gachon University Gil Oriental Medical Hospital | Gachon University Gil Oriental Medicine Hospital | Gachon University Medical Center | Gachon university of Gil oriental hospital | Gachon University of Medicine and Science | Gachon University of Medicine and Science Gil Medical Center | Gachon University of Oriental Hospital | Gil Medical Center | Gil Medical Center Gachon University | Kyungmi Kim
Highest phase reached
Phase 4
First clinical trial
Aug 1, 2003Last known activity
Dec 1, 2025
Timeline
1930s
- Jan 1, 1939
Gachon University— Founded
Drugs by trial phase (119 distinct, 102 trials)
Phase 4 (35 own, 0 via acquisition)
Phase 3 (29 own, 0 via acquisition)
Phase 2 (23 own, 0 via acquisition)
Phase 1 (12 own, 0 via acquisition)
Other trials (20 own, 0 via acquisition)
Indications
Studied for
- Acute Kidney Injury
- Angina Pectoris
- Angina, Stable
- Anovulation
- Arthritis
- Arthritis, Juvenile
- Arthritis, Psoriatic
- Atrial Fibrillation
- Back Pain
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Colorectal Neoplasms
- Coronary Artery Disease
- Coronary Disease
- Cryopyrin-Associated Periodic Syndromes
- Dermatitis
- Dermatitis, Atopic
- Diabetic Neuropathies
- Dyslipidemias
- Eczema
- Encephalitis
- Encephalitis, Japanese
- Essential Hypertension
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis, Chronic
- Hypercholesterolemia
- Hyperlipidemia, Familial Combined
- Hyperlipidemias
- Hyperlipoproteinemias
- Hypersensitivity
- Hypertension
- Hypertriglyceridemia
- Infertility
- Influenza, Human
- Ischemia
- Kidney Diseases
- Leiomyosarcoma
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Accelerated Phase
- Leukemia, Myeloid, Chronic-Phase
- Liver Diseases
- Low Back Pain
- Lung Diseases
- Lung Diseases, Obstructive
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, B-Cell, Marginal Zone
- Metabolic Syndrome
- Multiple Myeloma
- Myelodysplastic Syndromes
- Myocardial Ischemia
- Nausea
- Neoplasm Metastasis
- Neoplasms, Plasma Cell
- Obesity
- Osteoarthritis
- Osteoarthritis, Knee
- Pancreatic Neoplasms
- Pulmonary Disease, Chronic Obstructive
- Renal Insufficiency
- Renal Insufficiency, Chronic
- Rhinitis
- Rhinitis, Allergic
- Small Cell Lung Carcinoma
- Spondylitis
- Spondylitis, Ankylosing
- Stomach Neoplasms
- Syndrome
- Vomiting
Recent trials (50)
- NCT07227428CollaboratorPhase 4Dec 1, 2025
- NCT07147114Lead sponsorPhase 4Oct 31, 2025
- NCT07147114Sponsor investigatorPhase 4Oct 31, 2025
- NCT06622603CollaboratorPhase 4Oct 15, 2024
- NCT05188378Overall official - principal investigatorPhase 1Dec 22, 2021
- NCT04494269Overall official - principal investigatorPhase 1Sep 8, 2020
- NCT04014803CollaboratorPhase 4Jul 8, 2019
- NCT03950843Overall official - principal investigatorPhase 3Apr 23, 2019
- NCT03920579Overall official - principal investigatorPhase 1Apr 1, 2019
- NCT03802526Overall official - principal investigatorPhase 1Mar 8, 2019
- NCT03790033Overall official - principal investigatorPhase 2/Phase 3Dec 11, 2018
- NCT03790033Lead sponsorPhase 2/Phase 3Dec 11, 2018
- NCT03790033Reponsible party - principal investigatorPhase 2/Phase 3Dec 11, 2018
- NCT03625050Reponsible party - principal investigatorPhase 2Sep 1, 2018
- NCT03625050Overall official - principal investigatorPhase 2Sep 1, 2018
Details
- Founded
- Seongnam, KR Jan 1, 1939
- Last known activity
- Dec 1, 2025